For: | Bellanti JA. The long COVID syndrome: A conundrum for the allergist/immunologist. Allergy Asthma Proc 2022;43:368-74. [PMID: 36065103 DOI: 10.2500/aap.2022.43.220059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Akula SM, Williams JF, Pokhrel LR, Bauer AN, Rajput S, Cook PP. Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients. Viruses 2022;14. [PMID: 36560686 DOI: 10.3390/v14122681] [Reference Citation Analysis] |
2 | Bellanti JA, Settipane RA. A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors. Allergy Asthma Proc 2022;43:471-3. [PMID: 36335419 DOI: 10.2500/aap.2022.43.220081] [Reference Citation Analysis] |
3 | Bellanti JA, Settipane RA. Asthma biomarkers and COVID-19 continue to dominate current medical issues. Allergy Asthma Proc 2022;43:363-7. [PMID: 36065102 DOI: 10.2500/aap.2022.43.220062] [Reference Citation Analysis] |